Literature DB >> 18719908

Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study.

Paul Knaapen1, Maarten de Mulder, Friso M van der Zant, Hans O Peels, Jos W R Twisk, Albert C van Rossum, Jan H Cornel, Victor A W M Umans.   

Abstract

BACKGROUND: Primary percutaneous coronary intervention (PCI) performed in large community hospitals without cardiac surgery back-up facilities (off-site) reduces door-to-balloon time compared with emergency transferal to tertiary interventional centers (on-site). The present study was performed to explore whether off-site PCI for acute myocardial infarction results in reduced infarct size. METHODS AND
RESULTS: One hundred twenty-eight patients with acute ST-segment elevation myocardial infarction were randomly assigned to undergo primary PCI at the off-site center (n = 68) or to transferal to an on-site center (n = 60). Three days after PCI, (99m)Tc-sestamibi SPECT was performed to estimate infarct size. Off-site PCI significantly reduced door-to-balloon time compared with on-site PCI (94 +/- 54 versus 125 +/- 59 min, respectively, p < 0.01), although symptoms-to-treatment time was only insignificantly reduced (257 +/- 211 versus 286 +/- 146 min, respectively, p = 0.39). Infarct size was comparable between treatment centers (16 +/- 15 versus 14 +/- 12%, respectively p = 0.35). Multivariate analysis revealed that TIMI 0/1 flow grade at initial coronary angiography (OR 3.125, 95% CI 1.17-8.33, p = 0.023), anterior wall localization of the myocardial infarction (OR 3.44, 95% CI 1.38-8.55, p < 0.01), and development of pathological Q-waves (OR 5.07, 95% CI 2.10-12.25, p < 0.01) were independent predictors of an infarct size > 12%.
CONCLUSIONS: Off-site PCI reduces door-to-balloon time compared with transferal to a remote on-site interventional center but does not reduce infarct size. Instead, pre-PCI TIMI 0/1 flow, anterior wall infarct localization, and development of Q-waves are more important predictors of infarct size.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719908     DOI: 10.1007/s00259-008-0917-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  Should patients with acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in community? The case for community hospital angioplasty.

Authors:  Thomas P Wharton
Journal:  Circulation       Date:  2005-11-29       Impact factor: 29.690

2.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

3.  Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.

Authors:  Gjin Ndrepepa; Adnan Kastrati; Markus Schwaiger; Julinda Mehilli; Christina Markwardt; Alban Dibra; Josef Dirschinger; Albert Schömig
Journal:  J Nucl Med       Date:  2005-11       Impact factor: 10.057

4.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

5.  The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study.

Authors:  James C C Moon; Diego Perez De Arenaza; Andrew G Elkington; Anil K Taneja; Anna S John; Duolao Wang; Rajesh Janardhanan; Roxy Senior; Avijit Lahiri; Philip A Poole-Wilson; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

6.  Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.

Authors:  B R Brodie; T D Stuckey; T C Wall; G Kissling; C J Hansen; D B Muncy; R A Weintraub; T A Kelly
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

7.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging.

Authors:  Holger Thiele; Mathias J Kappl; Axel Linke; Sandra Erbs; Enno Boudriot; Alexander Lembcke; Dietmar Kivelitz; Gerhard Schuler
Journal:  Eur Heart J       Date:  2007-06-06       Impact factor: 29.983

10.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  1 in total

1.  Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions.

Authors:  M de Mulder; F M van der Zant; P Knaapen; J H Cornel; V A W M Umans
Journal:  Neth Heart J       Date:  2011-02-08       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.